HealthEquity, Inc. (NASDAQ:HQY) Shares Acquired by Exchange Traded Concepts LLC

Exchange Traded Concepts LLC increased its stake in shares of HealthEquity, Inc. (NASDAQ:HQY) by 2.6% in the 4th quarter, HoldingsChannel reports. The firm owned 9,813 shares of the company’s stock after buying an additional 245 shares during the quarter. Exchange Traded Concepts LLC’s holdings in HealthEquity were worth $942,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Bank of Montreal Can raised its holdings in shares of HealthEquity by 10.5% in the second quarter. Bank of Montreal Can now owns 11,308 shares of the company’s stock worth $976,000 after acquiring an additional 1,077 shares during the last quarter. The Manufacturers Life Insurance Company increased its position in HealthEquity by 0.8% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 104,494 shares of the company’s stock worth $9,007,000 after purchasing an additional 879 shares in the last quarter. Algert Global LLC acquired a new position in HealthEquity in the 2nd quarter valued at about $748,000. Creative Planning lifted its holdings in HealthEquity by 25.0% in the 2nd quarter. Creative Planning now owns 19,926 shares of the company’s stock valued at $1,718,000 after purchasing an additional 3,983 shares in the last quarter. Finally, Truist Financial Corp boosted its stake in shares of HealthEquity by 7.0% during the 2nd quarter. Truist Financial Corp now owns 2,864 shares of the company’s stock worth $247,000 after purchasing an additional 188 shares during the last quarter. Hedge funds and other institutional investors own 99.55% of the company’s stock.

HealthEquity Stock Up 3.2 %

Shares of NASDAQ HQY opened at $107.71 on Wednesday. The stock has a fifty day moving average price of $99.74 and a 200 day moving average price of $87.87. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51. HealthEquity, Inc. has a 12-month low of $65.01 and a 12-month high of $107.89. The company has a market cap of $9.33 billion, a P/E ratio of 98.82, a P/E/G ratio of 1.86 and a beta of 0.54.

HealthEquity (NASDAQ:HQY) last posted its earnings results on Monday, December 9th. The company reported $0.59 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same period last year, the business posted $0.40 earnings per share. Research analysts anticipate that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

Analysts Set New Price Targets

HQY has been the topic of a number of analyst reports. Bank of America raised their target price on shares of HealthEquity from $100.00 to $120.00 and gave the stock a “buy” rating in a research report on Wednesday, November 13th. BTIG Research raised their price objective on HealthEquity from $110.00 to $130.00 and gave the stock a “buy” rating in a report on Thursday, November 14th. Barrington Research upped their target price on HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a research note on Monday, December 2nd. The Goldman Sachs Group started coverage on HealthEquity in a research note on Friday, November 15th. They issued a “neutral” rating and a $108.00 price target on the stock. Finally, Royal Bank of Canada upped their price objective on shares of HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a research note on Tuesday, December 10th. One investment analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $110.71.

Insider Buying and Selling

In other news, Director Frank Corvino sold 1,039 shares of the company’s stock in a transaction that occurred on Wednesday, November 6th. The stock was sold at an average price of $96.10, for a total transaction of $99,847.90. Following the completion of the transaction, the director now directly owns 3,784 shares of the company’s stock, valued at approximately $363,642.40. This represents a 21.54 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Stuart B. Parker sold 25,000 shares of the firm’s stock in a transaction that occurred on Thursday, December 12th. The stock was sold at an average price of $96.72, for a total value of $2,418,000.00. Following the completion of the sale, the director now directly owns 19,061 shares in the company, valued at approximately $1,843,579.92. This trade represents a 56.74 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 34,289 shares of company stock worth $3,355,718. 2.20% of the stock is currently owned by corporate insiders.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.